At a glance
ClinicalIndex Comparison RecordN/ACompleted· 156 enrolled
Drug / intervention
Observational study so no intervention in the patient.other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
French Prospective Observational Study In Intensive Care Unit (ICU) Patients Treated With Tigecycline
Wyeth is now a wholly owned subsidiary of Pfizer·observational·Posted Dec 1, 2008·Updated Dec 19, 2011
In Brief
An observational study evaluating Observational study so no intervention in the patient. for Bacterial Infections. Completed, enrolled 156 participants across 1 site.
Detailed Summary
This study will describe clinical outcome and safety data collected prospectively in subjects hospitalized in an intensive care unit (ICU) presenting with an infection for which treatment with tigecycline, alone or in combination, is planned. Data will be collected only from subjects providing informed consent.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBacterial Infections
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedDec 2008
Primary CompletionMay 2010
TodayJul 2026
First PostedDec 1, 2008
Enrollment StartSep 1, 2008
Primary CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.6 years ago
Interventions
Observational study so no intervention in the patient.other
Observational study so no intervention in the patient.